Innopain Overview
- Year Founded
-
2015
- Status
-
Out of Business
- Employees
-
1
- Latest Deal Type
-
Liquidation
Innopain General Information
Description
Developer of analgesic drugs designed to provide treatment of nociceptive, acute and chronic pain. The company's molecules offer the treatment without the side effects of existing opiate drugs, enabling doctors to treat patients without inducing many of the side effects associated with current therapies.
Contact Information
Website
www.innopain.comCorporate Office
- Biopole Clermont-Limagne
- 63360 Saint-Beauzire
- France
Corporate Office
- Biopole Clermont-Limagne
- 63360 Saint-Beauzire
- France
Innopain Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Bankruptcy: Liquidation | 10-Jul-2021 | Completed | Bankruptcy: Liquidation | |||
| 2. Accelerator/Incubator | 12-Jul-2017 | Completed | Generating Revenue | |||
| 1. Early Stage VC | $441K | $441K | Completed | Startup |
Innopain Signals
Innopain FAQs
-
When was Innopain founded?
Innopain was founded in 2015.
-
Where is Innopain headquartered?
Innopain is headquartered in Saint-Beauzire, France.
-
What is the size of Innopain?
Innopain has 1 total employees.
-
What industry is Innopain in?
Innopain’s primary industry is Drug Discovery.
-
Is Innopain a private or public company?
Innopain is a Private company.
-
What is Innopain’s current revenue?
The current revenue for Innopain is .
-
How much funding has Innopain raised over time?
Innopain has raised $441K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process